Goldman Sachs’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,642
| Closed | -$236K | – | 5971 |
|
|
2023
Q4 | $236K | Sell |
5,642
-12,072
| -68% | -$445K | ﹤0.01% | 5092 |
|
|
2023
Q3 | $668K | Buy |
17,714
+8,044
| +83% | +$302K | ﹤0.01% | 4501 |
|
|
2023
Q2 | $367K | Buy |
+9,670
| New | +$304K | ﹤0.01% | 4905 |
|
|
2022
Q4 | – | Sell |
-7,854
| Closed | -$235K | – | 6340 |
|
|
2022
Q3 | $235K | Sell |
7,854
-9,743
| -55% | -$336K | ﹤0.01% | 5409 |
|
|
2022
Q2 | $636K | Buy |
17,597
+8,635
| +96% | +$329K | ﹤0.01% | 4915 |
|
|
2022
Q1 | $388K | Buy |
8,962
+788
| +10% | +$36.8K | ﹤0.01% | 5497 |
|
|
2021
Q4 | $410K | Sell |
8,174
-702
| -8% | -$39.3K | ﹤0.01% | 5500 |
|
|
2021
Q3 | $565K | Sell |
8,876
-6,411
| -42% | -$444K | ﹤0.01% | 5126 |
|
|
2021
Q2 | $1.1M | Sell |
15,287
-2,294
| -13% | -$169K | ﹤0.01% | 4692 |
|
|
2021
Q1 | $1.3M | Buy |
17,581
+3,417
| +24% | +$259K | ﹤0.01% | 4403 |
|
|
2020
Q4 | $1.04M | Sell |
14,164
-5,251
| -27% | -$338K | ﹤0.01% | 4174 |
|
|
2020
Q3 | $1.06M | Buy |
19,415
+3,668
| +23% | +$228K | ﹤0.01% | 4033 |
|
|
2020
Q2 | $1.05M | Sell |
15,747
-11,199
| -42% | -$751K | ﹤0.01% | 3913 |
|
|
2020
Q1 | $1.65M | Buy |
26,946
+14,313
| +113% | +$1.06M | ﹤0.01% | 3433 |
|
|
2019
Q4 | $1.11M | Buy |
12,633
+2,234
| +21% | +$188K | ﹤0.01% | 4058 |
|
|
2019
Q3 | $785K | Sell |
10,399
-2,881
| -22% | -$234K | ﹤0.01% | 4181 |
|
|
2019
Q2 | $1.13M | Sell |
13,280
-5,627
| -30% | -$557K | ﹤0.01% | 3911 |
|
|
2019
Q1 | $2.04M | Sell |
18,907
-8,627
| -31% | -$859K | ﹤0.01% | 3627 |
|
|
2018
Q4 | $2.33M | Buy |
27,534
+5,335
| +24% | +$514K | ﹤0.01% | 3432 |
|
|
2018
Q3 | $2.18M | Sell |
22,199
-5,649
| -20% | -$611K | ﹤0.01% | 3539 |
|
|
2018
Q2 | $3.22M | Sell |
27,848
-5,256
| -16% | -$577K | ﹤0.01% | 3270 |
|
|
2018
Q1 | $3.27M | Sell |
33,104
-23,671
| -42% | -$2.4M | ﹤0.01% | 3233 |
|
|
2017
Q4 | $5.95M | Sell |
56,775
-67,713
| -54% | -$7.44M | ﹤0.01% | 2864 |
|
|
2017
Q3 | $14M | Buy |
124,488
+19,423
| +18% | +$2.11M | ﹤0.01% | 2275 |
|
|
2017
Q2 | $11.8M | Sell |
105,065
-5,635
| -5% | -$637K | ﹤0.01% | 2374 |
|
|
2017
Q1 | $12.9M | Sell |
110,700
-2,818
| -2% | -$312K | ﹤0.01% | 2213 |
|
|
2016
Q4 | $12M | Sell |
113,518
-293,259
| -72% | -$30.7M | ﹤0.01% | 2324 |
|
|
2016
Q3 | $45M | Sell |
406,777
-60,183
| -13% | -$7.97M | 0.02% | 1287 |
|
|
2016
Q2 | $68M | Buy |
466,960
+286,329
| +159% | +$40.6M | 0.03% | 894 |
|
|
2016
Q1 | $25.9M | Sell |
180,631
-27,192
| -13% | -$3.86M | 0.01% | 1534 |
|
|
2015
Q4 | $32.1M | Buy |
207,823
+148,195
| +249% | +$21.6M | 0.01% | 1431 |
|
|
2015
Q3 | $8.52M | Buy |
59,628
+12,122
| +26% | +$1.69M | ﹤0.01% | 2383 |
|
|
2015
Q2 | $6.83M | Sell |
47,506
-12,790
| -21% | -$1.82M | ﹤0.01% | 2667 |
|
|
2015
Q1 | $8.5M | Buy |
60,296
+19,481
| +48% | +$3M | ﹤0.01% | 2434 |
|
|
2014
Q4 | $6.05M | Buy |
40,815
+15,969
| +64% | +$2.35M | ﹤0.01% | 2816 |
|
|
2014
Q3 | $3.82M | Buy |
24,846
+12,452
| +100% | +$1.87M | ﹤0.01% | 3285 |
|
|
2014
Q2 | $1.74M | Buy |
12,394
+10,425
| +529% | +$1.16M | ﹤0.01% | 4137 |
|
|
2014
Q1 | $219K | Sell |
1,969
-949
| -33% | -$103K | ﹤0.01% | 6008 |
|
|
2013
Q4 | $289K | Buy |
+2,918
| New | +$253K | ﹤0.01% | 5720 |
|
Other funds holding TARO
KAM
BIP
EP
